Visioneering Technologies (ASX:VTI) has announced plans to delist from the ASX, with a vote scheduled for 10 January 2025.

Cataracts are a common yet often misunderstood eye condition and remain one of the leading causes of vision impairment ...

Myopia control spectacles have not yet secured US FDA approval, but these treatments show promise for limiting myopia ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...

Dr. Rex Hamilton, M.D., is a leading authority in ophthalmology and refractive surgery, renowned for his expertise in ...

Equities research analysts at William Blair lifted their Q4 2025 earnings per share (EPS) estimates for shares of Cooper Companies in a report issued on Monday, December 9th. William Blair analyst M.

Fmr LLC cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 24.8% in the 3rd quarter, ...